본문 바로가기

감염내과/뇌수막염

수막염에서 권고되는 경험적 항생제, Recommendations for empiric antimicrobial therapy for purulent meningitis

728x90
반응형

Recommendations for empiric antimicrobial therapy for purulent meningitis based on patient age and specific predisposing condition*

Predisposing factor

Common bacterial pathogens

Antimicrobial therapy

Age

<1 month

Streptococcus agalactiae, Escherichia coli, Listeria monocytogenes

Ampicillin plus cefotaxime; OR ampicillin plus an aminoglycoside

1 to 23 months

Streptococcus pneumoniae, Neisseria meningitidis, S. agalactiae, Haemophilus influenzae, E. coli

Vancomycin plus a third-generation cephalosporin¶Δ◊

2 to 50 years

N. meningitidis, S. pneumoniae

Vancomycin plus a third-generation cephalosporin¶Δ◊

>50 years

S. pneumoniae, N. meningitidis, L. monocytogenes, aerobic gram-negative bacilli

Vancomycin plus ampicillin plus a third-generation cephalosporin¶Δ

Head trauma

Basilar skull fracture

S. pneumoniae, H. influenzae, group A beta-hemolytic streptococci

Vancomycin plus a third-generation cephalosporin¶Δ

Penetrating trauma

Staphylococcus aureus, coagulase-negative staphylococci (especially Staphylococcus epidermidis), aerobic gram-negative bacilli (including Pseudomonas aeruginosa)

Vancomycin plus cefepime; OR vancomycin plus ceftazidime; OR vancomycin plus meropenem

Postneurosurgery

Aerobic gram-negative bacilli (including P. aeruginosa), S. aureus, coagulase-negative staphylococci (especially S. epidermidis)

Vancomycin plus cefepime; OR vancomycin plus ceftazidime; OR vancomycin plus meropenem

Immunocompromised state

S. pneumoniae, N. meningitidis, L. monocytogenes, aerobic gram-negative bacilli (including P. aeruginosa)

Vancomycin plus ampicillin plus cefepime; OR vancomycin plus meropenem§

* For recommended dosages for adults, refer to the UpToDate table on recommended intravenous dosages of antimicrobial therapy for adults with bacterial meningitis.

¶ Ceftriaxone or cefotaxime.

Δ Some experts would add rifampin if dexamethasone is also given.

◊ Add ampicillin if meningitis caused by Listeria monocytogenes is suspected.

§ Meropenem provides sufficient coverage for Listeria when used as part of an initial regimen. However, if Listeria is identified, the patient should generally be switched to a regimen that includes ampicillin. Refer to the UpToDate topic that discusses treatment of Listeria for a discussion of regimen selection.

Modified with permission from: Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39:1267. Copyright © 2004 University of Chicago Press.

REF. UpToDate 2019.12.26

728x90
반응형